European Commission opens antitrust probe into Align Technology's Invisalign, iTero practices in EEA

Traders Union
All News
Geopolitics & Trade
EC probes Align antitrust case

Highlights

European Commission launched its first antitrust probe in the medical devices sector, targeting Align Technology's Invisalign and iTero practices in the EEA.
Investigation focuses on whether Align Technology has restricted scanner interoperability since 2017, allegedly refusing to accept or integrate rival digital scans for Invisalign orders.
Commission argues Align's strategies may create a closed ecosystem, shielding iTero scanners and protecting Invisalign's dominance, possibly violating Article 102 TFEU and Article 54 EEA.

Investigation centers on scanner interoperability

As reported by the European Commission, the formal probe assesses whether Align Technology has breached EU competition rules by tying its market-leading Invisalign clear aligners to its iTero intra-oral scanners in the EEA.

The Commission says the investigation follows a complaint by a competitor and marks the first formal antitrust investigation in the medical devices sector. It says intra-oral scanners act as the digital entry point to the clear aligner market because dental professionals use the scans to order orthodontic products, including clear aligners.

Regulators are examining what they describe as a restrictive interoperability strategy built around two measures since 2017. These include an alleged refusal to approve competing advanced scanners for automated submission of digital scans for Invisalign orders, and an alleged refusal to accept scans generated by other scanners even when those files are based on industry standards.

Potential impact on EU dental device competition

The Commission says those practices may create a closed ecosystem around Invisalign by limiting dentists' ability to order the aligners through rival intra-oral scanners. In its view, that could shield iTero scanners from competition while also protecting Align's possible dominance in clear aligners.

Align Technology, headquartered in the U.S., specializes in Invisalign aligners and iTero scanners. The Commission notes Invisalign held a near monopoly in clear aligners until 2017 because of patent protection, a position that adds weight to its assessment of potential market power.

If the conduct is proven, it may amount to an abuse of a dominant position under Article 102 of the Treaty on the Functioning of the European Union and Article 54 of the EEA Agreement. The Commission says it will pursue the in-depth investigation as a priority, while stressing that opening formal proceedings does not prejudge the final outcome.

In our earlier article on Alphabet (GOOGL), we covered the stock’s rebound after a sharp pullback, supported by optimism around AI infrastructure demand and strong Google Cloud momentum. We also noted that heavy capex plans and ongoing U.S. and EU antitrust pressure remained key overhangs, limiting valuation upside despite improving sentiment.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.